JPWO2022025281A1 - - Google Patents
Info
- Publication number
- JPWO2022025281A1 JPWO2022025281A1 JP2022539625A JP2022539625A JPWO2022025281A1 JP WO2022025281 A1 JPWO2022025281 A1 JP WO2022025281A1 JP 2022539625 A JP2022539625 A JP 2022539625A JP 2022539625 A JP2022539625 A JP 2022539625A JP WO2022025281 A1 JPWO2022025281 A1 JP WO2022025281A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020129730 | 2020-07-30 | ||
| PCT/JP2021/028441 WO2022025281A1 (ja) | 2020-07-30 | 2021-07-30 | 水性組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022025281A1 true JPWO2022025281A1 (https=) | 2022-02-03 |
Family
ID=80036439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539625A Pending JPWO2022025281A1 (https=) | 2020-07-30 | 2021-07-30 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230285564A1 (https=) |
| EP (1) | EP4176881A4 (https=) |
| JP (1) | JPWO2022025281A1 (https=) |
| KR (1) | KR20230047401A (https=) |
| CN (1) | CN116568286A (https=) |
| AU (1) | AU2021318237A1 (https=) |
| CA (1) | CA3190313A1 (https=) |
| TW (1) | TW202220659A (https=) |
| WO (1) | WO2022025281A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220044288A (ko) * | 2019-08-07 | 2022-04-07 | 로토 세이야쿠 가부시키가이샤 | 누액 분비 촉진용 안과 조성물 |
| EP4674401A3 (en) * | 2019-12-27 | 2026-02-25 | Rohto Pharmaceutical Co., Ltd | Container accommodating an aqueous ophthalmic composition comprising delgocitinib |
| AU2021318236A1 (en) * | 2020-07-30 | 2023-03-09 | Rohto Pharmaceutical Co., Ltd. | Aqueous composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007007832A1 (ja) * | 2005-07-13 | 2007-01-18 | Santen Pharmaceutical Co., Ltd. | 眼科用防腐組成物 |
| JP2011225626A (ja) * | 2001-02-01 | 2011-11-10 | Rohto Pharmaceutical Co Ltd | 点眼剤 |
| WO2015060208A1 (ja) * | 2013-10-21 | 2015-04-30 | 日本たばこ産業株式会社 | 眼疾患の治療剤又は予防剤 |
| WO2021025129A1 (ja) * | 2019-08-07 | 2021-02-11 | ロート製薬株式会社 | 涙液分泌促進用眼科組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101454674B1 (ko) * | 2006-03-17 | 2014-10-27 | 존슨 앤드 존슨 비젼 케어, 인코포레이티드 | 산화에 불안정한 성분을 포함하는 안정화된 안과용 조성물 |
| WO2008093358A2 (en) * | 2007-01-29 | 2008-08-07 | Sun Pharmaceutical Industries Limited | Aqueous topical solution containing olopatadine |
| EA201001326A1 (ru) * | 2008-02-19 | 2011-04-29 | Марвел Лайфсайнсез Лтд. | Стерильные офтальмологические композиции и способ их получения |
| HK1251223A1 (en) | 2015-07-07 | 2019-01-25 | Japan Tobacco, Inc. | Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof |
| KR102702286B1 (ko) | 2016-12-21 | 2024-09-04 | 니뽄 다바코 산교 가부시키가이샤 | 7H-피롤로[2,3-d]피리미딘 유도체의 제조 방법 및 그의 공결정 |
-
2021
- 2021-07-30 US US18/018,108 patent/US20230285564A1/en active Pending
- 2021-07-30 TW TW110128201A patent/TW202220659A/zh unknown
- 2021-07-30 CA CA3190313A patent/CA3190313A1/en active Pending
- 2021-07-30 EP EP21850581.6A patent/EP4176881A4/en active Pending
- 2021-07-30 JP JP2022539625A patent/JPWO2022025281A1/ja active Pending
- 2021-07-30 CN CN202180059043.5A patent/CN116568286A/zh active Pending
- 2021-07-30 KR KR1020237005629A patent/KR20230047401A/ko active Pending
- 2021-07-30 AU AU2021318237A patent/AU2021318237A1/en active Pending
- 2021-07-30 WO PCT/JP2021/028441 patent/WO2022025281A1/ja not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011225626A (ja) * | 2001-02-01 | 2011-11-10 | Rohto Pharmaceutical Co Ltd | 点眼剤 |
| WO2007007832A1 (ja) * | 2005-07-13 | 2007-01-18 | Santen Pharmaceutical Co., Ltd. | 眼科用防腐組成物 |
| WO2015060208A1 (ja) * | 2013-10-21 | 2015-04-30 | 日本たばこ産業株式会社 | 眼疾患の治療剤又は予防剤 |
| WO2021025129A1 (ja) * | 2019-08-07 | 2021-02-11 | ロート製薬株式会社 | 涙液分泌促進用眼科組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4176881A4 (en) | 2024-07-31 |
| EP4176881A1 (en) | 2023-05-10 |
| CN116568286A (zh) | 2023-08-08 |
| KR20230047401A (ko) | 2023-04-07 |
| TW202220659A (zh) | 2022-06-01 |
| AU2021318237A1 (en) | 2023-03-09 |
| WO2022025281A1 (ja) | 2022-02-03 |
| CA3190313A1 (en) | 2022-02-03 |
| US20230285564A1 (en) | 2023-09-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240722 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250722 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250918 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251120 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251216 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260316 |